Skip to main content
Brian Zelickson, MD, Dermatology, Minneapolis, MN

BrianDavidZelicksonMD

Dermatology Minneapolis, MN

Assistant Professor of Dermatology, University Minn

Dr. Zelickson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Zelickson's full profile

Already have an account?

  • Office

    825 Nicollet Mall
    Suite 1002
    Minneapolis, MN 55402
    Phone+1 612-338-0711
    Fax+1 612-332-3663

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 1987 - 1990
  • Hennepin Healthcare
    Hennepin HealthcareInternship, Transitional Year, 1986 - 1987
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 1986

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2016 - 2026
  • NY State Medical License
    NY State Medical License 2024 - 2026
  • MN State Medical License
    MN State Medical License 1987 - 2025
  • PA State Medical License
    PA State Medical License 2016 - 2018
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Super Doctor SuperDoctors.com
  • Top MD Consumers Checkbook
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • MD Complete Announces A New Form of Hyaluronic Acid, Modified to Make It More Active, More Mobile and More Effective in Skincare
    MD Complete Announces A New Form of Hyaluronic Acid, Modified to Make It More Active, More Mobile and More Effective in SkincareJune 24th, 2019
  • Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face
    Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the FaceJanuary 8th, 2019
  • “Outstanding Clearance Rates” for Sebaceous Hyperplasia Facial Lesions Seen with NPS
    “Outstanding Clearance Rates” for Sebaceous Hyperplasia Facial Lesions Seen with NPSJanuary 7th, 2019
  • Join now to see all

Professional Memberships